Annual ROE
-15.85%
-30.08%-211.38%
December 1, 2023
Summary
- As of February 6, 2025, CSCI annual return on equity is -15.85%, with the most recent change of -30.08% (-211.38%) on December 1, 2023.
- During the last 3 years, CSCI annual ROE has fallen by -23.90% (-296.89%).
- CSCI annual ROE is now -108.50% below its all-time high of 186.39%, reached on December 1, 2008.
Performance
CSCI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-47.02%
-23.66%-101.28%
September 1, 2024
Summary
- As of February 6, 2025, CSCI quarterly return on equity is -47.02%, with the most recent change of -23.66% (-101.28%) on September 1, 2024.
- Over the past year, CSCI quarterly ROE has dropped by -31.43% (-201.60%).
- CSCI quarterly ROE is now -106.70% below its all-time high of 701.64%, reached on March 1, 2004.
Performance
CSCI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CSCI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -211.4% | -201.6% |
| 3 y3 years | -296.9% | -201.6% |
| 5 y5 years | -1100.8% | -201.6% |
CSCI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -211.4% | at low | -327.9% | at low |
| 5 y | 5-year | -211.4% | at low | -327.9% | at low |
| alltime | all time | -108.5% | +95.0% | -106.7% | +98.9% |
COSCIENS Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -47.02%(+101.3%) |
| Jun 2024 | - | -23.36%(+9.5%) |
| Mar 2024 | - | -21.34%(+36.9%) |
| Dec 2023 | -15.85%(-211.4%) | -15.59%(+75.4%) |
| Sep 2023 | - | -8.89%(+281.5%) |
| Jun 2023 | - | -2.33%(-132.2%) |
| Mar 2023 | - | 7.24%(-51.2%) |
| Dec 2022 | 14.23%(+10.0%) | 14.83%(-27.2%) |
| Sep 2022 | - | 20.37%(-1.3%) |
| Jun 2022 | - | 20.63%(+18.2%) |
| Mar 2022 | - | 17.45%(+33.6%) |
| Dec 2021 | 12.94%(+60.7%) | 13.06%(+97.3%) |
| Sep 2021 | - | 6.62%(+66.3%) |
| Jun 2021 | - | 3.98%(-27.2%) |
| Mar 2021 | - | 5.47%(-29.8%) |
| Dec 2020 | 8.05%(-258.5%) | 7.79%(-26.4%) |
| Sep 2020 | - | 10.58%(+11.5%) |
| Jun 2020 | - | 9.49%(+295.4%) |
| Mar 2020 | - | 2.40%(-147.0%) |
| Dec 2019 | -5.08%(+284.8%) | -5.11%(+39.6%) |
| Sep 2019 | - | -3.66%(-19.6%) |
| Jun 2019 | - | -4.55%(+63.7%) |
| Mar 2019 | - | -2.78%(+110.6%) |
| Dec 2018 | -1.32%(-70.1%) | -1.32%(-87.6%) |
| Sep 2018 | - | -10.64%(+33.8%) |
| Jun 2018 | - | -7.95%(+41.0%) |
| Mar 2018 | - | -5.64%(+30.0%) |
| Dec 2017 | -4.41%(-118.3%) | -4.34%(-233.1%) |
| Sep 2017 | - | 3.26%(-39.4%) |
| Jun 2017 | - | 5.38%(-60.9%) |
| Mar 2017 | - | 13.77%(-45.6%) |
| Dec 2016 | 24.11%(-74.6%) | 25.32%(-60.3%) |
| Sep 2016 | - | 63.80%(-36.7%) |
| Jun 2016 | - | 100.81%(-12.8%) |
| Mar 2016 | - | 115.60%(-3.5%) |
| Dec 2015 | 94.86%(-29.8%) | 119.83%(+127.6%) |
| Sep 2015 | - | 52.65%(-7.5%) |
| Jun 2015 | - | 56.92%(-27.1%) |
| Mar 2015 | - | 78.04%(-40.2%) |
| Dec 2014 | 135.15%(-0.4%) | 130.42%(-19.6%) |
| Sep 2014 | - | 162.13%(-0.3%) |
| Jun 2014 | - | 162.67%(-909.3%) |
| Mar 2014 | - | -20.10%(-127.6%) |
| Dec 2013 | 135.75%(-165.3%) | 72.92%(+291.0%) |
| Sep 2013 | - | 18.65%(-122.1%) |
| Jun 2013 | - | -84.53%(+104.2%) |
| Mar 2013 | - | -41.39%(-74.4%) |
| Dec 2012 | -207.84%(-286.3%) | -161.83%(+843.1%) |
| Sep 2012 | - | -17.16%(+156.9%) |
| Jun 2012 | - | -6.68%(-101.9%) |
| Mar 2012 | - | 344.91%(-123.0%) |
| Dec 2011 | 111.56%(-257.6%) | -1502.65%(+845.3%) |
| Sep 2011 | - | -158.96%(-2.0%) |
| Jun 2011 | - | -162.14%(+30.2%) |
| Mar 2011 | - | -124.55%(+158.5%) |
| Dec 2010 | -70.79% | -48.19%(-268.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | 28.64%(-22.5%) |
| Jun 2010 | - | 36.94%(+58.8%) |
| Mar 2010 | - | 23.26%(+112.8%) |
| Dec 2009 | 5.05%(-97.3%) | 10.93%(-70.5%) |
| Sep 2009 | - | 36.99%(-55.2%) |
| Jun 2009 | - | 82.52%(-68.3%) |
| Mar 2009 | - | 260.62%(-106.0%) |
| Dec 2008 | 186.39%(-221.5%) | -4344.33%(+1206.8%) |
| Sep 2008 | - | -332.45%(+62.9%) |
| Jun 2008 | - | -204.07%(+50.3%) |
| Mar 2008 | - | -135.75%(+27.7%) |
| Dec 2007 | -153.37%(+115.9%) | -106.33%(+17.5%) |
| Sep 2007 | - | -90.49%(+50.6%) |
| Jun 2007 | - | -60.10%(-10.1%) |
| Mar 2007 | - | -66.86%(-2.6%) |
| Dec 2006 | -71.04%(+256.1%) | -68.65%(+719.2%) |
| Sep 2006 | - | -8.38%(-45.2%) |
| Jun 2006 | - | -15.30%(-212.4%) |
| Mar 2006 | - | 13.61%(-161.8%) |
| Dec 2005 | -19.95%(-88.3%) | -22.04%(-84.8%) |
| Sep 2005 | - | -144.88%(-35.7%) |
| Jun 2005 | - | -225.31%(-10.6%) |
| Mar 2005 | - | -251.94%(+88.1%) |
| Dec 2004 | -169.83%(-246.9%) | -133.97%(+5.0%) |
| Sep 2004 | - | -127.62%(-242.4%) |
| Jun 2004 | - | 89.65%(-87.2%) |
| Mar 2004 | - | 701.64%(-154.4%) |
| Dec 2003 | 115.64%(-752.6%) | -1288.72%(+458.3%) |
| Sep 2003 | - | -230.83%(+203.4%) |
| Jun 2003 | - | -76.08%(+109.6%) |
| Mar 2003 | - | -36.29%(+167.4%) |
| Dec 2002 | -17.72%(-158.2%) | -13.57%(-41.6%) |
| Sep 2002 | - | -23.23%(+726.7%) |
| Jun 2002 | - | -2.81%(-109.8%) |
| Mar 2002 | - | 28.69%(+22.3%) |
| Dec 2001 | 30.43%(-20.6%) | 23.45%(-55.9%) |
| Sep 2001 | - | 53.18%(+18.7%) |
| Jun 2001 | - | 44.80%(+18.9%) |
| Mar 2001 | - | 37.67%(-8.0%) |
| Dec 2000 | 38.31%(-19.1%) | 40.94%(-21.1%) |
| Sep 2000 | - | 51.87%(-11.2%) |
| Jun 2000 | - | 58.40%(-4.5%) |
| Mar 2000 | - | 61.15%(-4.5%) |
| Dec 1999 | 47.37%(-114.9%) | 64.05%(-87.9%) |
| Sep 1999 | - | 528.21%(-180.6%) |
| Jun 1999 | - | -655.01%(+104.0%) |
| Mar 1999 | - | -321.09%(+48.5%) |
| Dec 1998 | -317.51%(+42.3%) | -216.29%(+14.4%) |
| Sep 1998 | - | -189.08%(+79.8%) |
| Jun 1998 | - | -105.16%(+20.9%) |
| Mar 1998 | - | -86.95%(+4.3%) |
| Dec 1997 | -223.05%(+382.3%) | -83.38%(+274.7%) |
| Sep 1997 | - | -22.25%(+62.4%) |
| Jun 1997 | - | -13.70%(+142.5%) |
| Mar 1997 | - | -5.65% |
| Dec 1996 | -46.25% | - |
FAQ
- What is COSCIENS Biopharma annual return on equity?
- What is the all time high annual ROE for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual ROE year-on-year change?
- What is COSCIENS Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly ROE year-on-year change?
What is COSCIENS Biopharma annual return on equity?
The current annual ROE of CSCI is -15.85%
What is the all time high annual ROE for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual return on equity is 186.39%
What is COSCIENS Biopharma annual ROE year-on-year change?
Over the past year, CSCI annual return on equity has changed by -30.08% (-211.38%)
What is COSCIENS Biopharma quarterly return on equity?
The current quarterly ROE of CSCI is -47.02%
What is the all time high quarterly ROE for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly return on equity is 701.64%
What is COSCIENS Biopharma quarterly ROE year-on-year change?
Over the past year, CSCI quarterly return on equity has changed by -31.43% (-201.60%)